About
Cannabinoid Overdose
Areas of Focus
Categories
Small Molecule PharmaceuticalSouthwestern U.S.
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
230
By Phase
PHASE1: 1PHASE2: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07211607Lead Sponsor
I.V. Selonabant in Healthy Adult Subjects
PHASE1Recruiting
40 participants
Started: Sep 22, 2025 · Completed: Aug 25, 2026
NCT06017622Lead Sponsor
Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression
N/AActive, not recruiting
36 participants
Started: Jun 1, 2023 · Completed: Jun 30, 2026
NCT05282797Lead Sponsor
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test
PHASE2Completed
154 participants
Started: Dec 15, 2021 · Completed: Aug 26, 2023
Locations (1)
Headquarters
Austin, TX, United States
Map
Loading map...